Sectors
CVKD
Cadrenal Therapeutics, Inc. Common Stock
1.98
1 x 1.92
1 x 2.01
bid
ask
+
0.04
1.80%
09:36 AM
timesize
| Ytd | -70.87% | |
| 1y | -81.95% |
1.95
day range
1.98
1.86
52 week range
14.64
| Open | 1.98 | Prev Close | 1.94 | Low | 1.95 | High | 1.98 | Mkt Cap | 6.12M |
| Vol | 3.23K | Avg Vol | 70.30K | EPS | -5.63 | P/E | -0.35 | Forward P/E | -3.02 |
| Beta | 1.84 | Short Ratio | 1.17 | Inst. Own | 4.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-21 | 50-d Avg | 2.95 | 200-d Avg | 6.52 | 1yr Est | 35.67 |
| Income Statement | |||
| Operating Expenses | 2.51M | ||
| Research and Development Expense | 771.51K | ||
| Selling, General and Administrative Expense | 1.74M | ||
| Operating Income | -2.51M | ||
| Net Income | -2.50M | ||
| Net Income Common Stock | -2.50M | ||
| Net Income Common Stock (USD) | -2.50M | ||
| Consolidated Income | -2.50M | ||
| Earnings per Basic Share | -1.04 | ||
| Earnings per Basic Share (USD) | -1.04 | ||
| Earnings per Diluted Share | -1.04 | ||
| Earning Before Interest & Taxes (EBIT) | -2.50M | ||
| Earning Before Interest & Taxes (USD) | -2.50M | ||
| Weighted Average Shares | 2.41M | ||
| Weighted Average Shares Diluted | 2.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.31M | ||
| Cash and Equivalents (USD) | 2.31M | ||
| Current Assets | 2.86M | ||
| Property, Plant & Equipment Net | 4.62K | ||
| Total Assets | 2.86M | ||
| Current Liabilities | 1.06M | ||
| Total Liabilities | 1.06M | ||
| Accumulated Retained Earnings (Deficit) | -41.46M | ||
| Shareholders Equity | 1.80M | ||
| Shareholders Equity (USD) | 1.80M | ||
| Assets Non-Current | 6.79K | ||
| Trade and Non-Trade Payables | 824.81K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 555.00 | ||
| Net Cash Flow from Financing | 1.30M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.70M | ||
| Issuance (Purchase) of Equity Shares | 1.30M | ||
| Net Cash Flow from Operations | -3.00M | ||
| Share Based Compensation | 252.36K | ||